Kendle further expands Asia-Pacific presence

By Staff reporter

- Last updated on GMT

Related tags Pharmacology Pharmaceutical industry

US CRO Kendle has set up three units in Malaysia, Thailand and the Philippines, further demonstrating the growing importance of the Asia Pacific for the contract research sector.

The new offices, which are in Kuala Lumpur, Bangkok and Manila, will focus on providing contract research services for the region’s biopharmaceutical development and manufacturing sector.

Ross Horsburgh, vice president of Kendle’s global clinical development operations explained that: “With more than half of the world’s population, Asia offers an abundance of patients in nearly every therapeutic area.”

He went on to say that: “Governments have highlighted biopharmaceutical development as a key pillar to their economies, resulting in much more favourable environments for global clinical development work​.”

According a recent study by the Tufts Center for the Study of Drug Development 65 per cent of all US Food and Drug Administration (FDA) regulated trials will take place outside the US, with a significant proportion being carried out in Asia.

Recognition of this trend coupled with an increasing awareness of the importance of local knowledge has seen a number of US contract research organisations (CRO), most recently Covance and PRA, invest in the region.

Cost of trials

While the potential of the Asian trial market is clearly a motivation for Kendle building its presence in the region, the cost savings provided by the region are also a factor.

In Q1, the firm reported a 45 per cent project cancellation rate, cut its 2009 earnings expectations and said that it was examining ways of reducing costs, including expanding it network in Asia.

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us


View more